These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23089529)

  • 61. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: Data from the Berlin AFibACS Registry.
    Maier B; Hegenbarth C; Theres H; Schoeller R; Schuehlen H; Behrens S;
    Cardiol J; 2014; 21(5):465-73. PubMed ID: 24142683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
    Ozawa T; Suda M; Ikegami R; Takano T; Wakasugi T; Yanagawa T; Tanaka K; Ozaki K; Hirono S; Minamino T
    Int Heart J; 2018 Jan; 59(1):21-26. PubMed ID: 29279531
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interventional cardiology: does an optimal antithrombotic regimen for PCI exist?
    Lincoff AM
    Nat Rev Cardiol; 2014 Jan; 11(1):10-2. PubMed ID: 24302216
    [No Abstract]   [Full Text] [Related]  

  • 64. Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
    Capodanno D; Angiolillo DJ
    Circ Cardiovasc Interv; 2014 Feb; 7(1):113-24. PubMed ID: 24550531
    [No Abstract]   [Full Text] [Related]  

  • 65. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
    Gibson CM; Mehran R; Bode C; Halperin J; Verheugt F; Wildgoose P; van Eickels M; Lip GY; Cohen M; Husted S; Peterson E; Fox K
    Am Heart J; 2015 Apr; 169(4):472-8.e5. PubMed ID: 25819853
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Bleeding Risk on Type of Stent Used in Patients Presenting With Acute Coronary Syndrome.
    Alraies MC; Lee SY; Lipinski MJ; Buchanan K; Steinvil A; Rogers T; Koifman E; Gai J; Torguson R; Ben-Dor I; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2017 Oct; 120(8):1272-1278. PubMed ID: 28826893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen JK; Cuisset T; Kirchhof P; Marín F;
    Eur Heart J; 2010 Jun; 31(11):1311-8. PubMed ID: 20447945
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
    Paikin JS; Wright DS; Crowther MA; Mehta SR; Eikelboom JW
    Circulation; 2010 May; 121(18):2067-70. PubMed ID: 20458022
    [No Abstract]   [Full Text] [Related]  

  • 69. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint.
    Gwyn JCV; Thomas MR; Kirchhof P
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):157-162. PubMed ID: 28329215
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Apixaban (Eliquis)--a new oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Feb; 55(1409):9-10. PubMed ID: 23381226
    [No Abstract]   [Full Text] [Related]  

  • 72. ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials.
    Cassese S; De Luca G; Ribichini F; Cernigliaro C; Sansa M; Versaci F; Proietti I; Stankovic G; Stojkovic S; Fernandez-Pereira C; Tomai F; Vassanelli C; Antoniucci D; Serruys PW; Kastrati A; Rodriguez AE
    Atherosclerosis; 2014 Dec; 237(2):410-7. PubMed ID: 25463066
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of antithrombotic therapy in patients undergoing invasive procedures.
    Baron TH; Kamath PS; McBane RD
    N Engl J Med; 2013 May; 368(22):2113-24. PubMed ID: 23718166
    [No Abstract]   [Full Text] [Related]  

  • 74. Renin-angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention.
    Xiao-Dong Z; Fei-Fei L; Zhan-Peng W; Xin-Xue L; Zhi-Min D
    Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):172-7. PubMed ID: 27185017
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.
    Chang KW; Arbit B; Hsu JC
    Int J Cardiol; 2017 Sep; 243():263-269. PubMed ID: 28595745
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence-based management of patients undergoing PCI: stent controversies.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.
    Chamberlain AM; Gersh BJ; Mills RM; Klaskala W; Alonso A; Weston SA; Roger VL
    Am J Cardiol; 2015 Apr; 115(8):1042-8. PubMed ID: 25726381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Percutaneous Coronary Intervention: 2015 in Review.
    Grines CL; Harjai KJ; Schreiber TL
    J Interv Cardiol; 2016 Feb; 29(1):11-26. PubMed ID: 26864949
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting: the real question nowadays is...].
    Rubboli A; Ricci Lucchi G; Vecchio S
    G Ital Cardiol (Rome); 2019 Jun; 20(6):396. PubMed ID: 31184327
    [No Abstract]   [Full Text] [Related]  

  • 80. The role of percutaneous coronary intervention in managing patients with stable ischemic heart disease.
    Herbert T; Rizzolo D
    JAAPA; 2020 Jun; 33(6):18-22. PubMed ID: 32384294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.